Is femoral artery calcification a sign of mortality in elderly hip fractures?

Year 2019, Volume: 13 Issue: 2, 98 - 101, 31.08.2019

Ozhan Pazarcı , Cihat Ekici Kemal Yazıcı Seyran Kılınç , Hayati Öztürk

Abstract

Objectives: It is important to determine the risks of
mortality in elderly patients with hip fractures. The aim of this study was to
investigate the effect of femoral artery calcification on mortality risk in
patients with cemented partial hip prosthesis.  

Methods: The study included 145 patients (≥65-years-old)
with cemented partial hip prosthesis operated following hip fracture. Patients
were divided into two groups: Group (1) included those without femoral artery
calcification, and Group (2) with femoral artery calcifications observed on
direct radiography. Age, gender, duration of hospitalization, time of death and
follow-up duration, ASA score, anesthesia type, fracture type, complication and
time of operation for patients were compared between two groups.  

Results: After exclusion of certain patients due to lack of
necessary information in their documents, a total of 116 patients were
investigated. The mean age of patients was 81.52±6.82. Mean follow-up duration
was 35.39 (range: 0–76) months. Three out of 116 patients died after some
complications during surgery. Mean time of death after surgery was 21.21 months
in Group 1 and 23.86 months in Group 2 (p=0.628).   

Conclusion: The results of this study showed that femoral
artery calcification in patients with cemented prosthesis due to hip fracture
at advanced age had no effect on mortality. However, there is a need for
advanced studies with larger patient groups.  

Keywords

arterial calcification, hip fracture, mortality

References

• Referans1 Abedin M, Tintut Y, Demer LL. Vascular calcification: Mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol. 2004;24(7):1161–70.
• Referans2 Kardos A, Casadei B. Hormone replacement therapy and ischaemic heart disease among postmenopausal women. J Cardiovasc Risk. 1999 Apr;6(2):105-12.
• Referans3 Cannata-Andia JB, Rodriguez-Garcia M, Carrillo-Lopez N, Naves-Diaz M, Diaz-Lopez B. Vascular Calcifications: Pathogenesis, Management, and Impact on Clinical Outcomes. J Am Soc Nephrol 2006;17(12_suppl_3):S267–73.
• Referans4 Abrahamsen B, Van Staa T, Ariely R, Olson M, Cooper C. Excess mortality following hip fracture: A systematic epidemiological review. Osteoporos Int. 2009;20(10):1633–50.
• Referans5 Negrete-Corona J and at all. Hip fracture as risk factor for mortality in patients over 65 years of age. Case-control study. Acta Ortop Mex. 2014 Nov-Dec;28(6):352-62.
• Referans6 Dhanwal DK, Dennison EM, Harvey NC, Cooper C. Epidemiology of hip fracture: Worldwide geographic variation. Indian J Orthop. 2011;45(1):15–22.
• Referans7 Uludağ Ö, Tutak A, Güler A, Doğukan M, Kaya R, Duran M. Kalça Kırığı sebebiyle Ameliyat Olmuş Yaşlı Hastalarda Albumin ve Hemoglobin Değerlerinin Hastanede Kalış Süresi ve Mortalite Üzerine Etkisinin Retrospektif İncelenmesi. Adıyaman Üniversitesi Sağlık Bilim Derg. 2018;4(1):637–47.
• Referans8 Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V. Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab. 2004;89(9):4246–53.
• Referans9 Marchais SJ, Gue AP, Boutouyrie P, Me F, Vernejoul M De. Association of Bone Activity , Calcium Load , Aortic Stiffness , and Calcifications in ESRD. 2008;1827–35.
• Referans10 Cannata-Andia JB, Roman-Garcia P, Hruska K. The connections between vascular calcification and bone health. Nephrol Dial Transplant. 2011;26(11):3429–36.
• Referans11 Maghraoui A El, Rezqi A, Mounach A, Achemlal L, Bezza A, Ghozlani I. Original article Relationship between vertebral fracture prevalence and abdominal aortic calcification in men. 2012;(June):1714–20.
• Referans12 Naves M. Progression of vascular calcifications is associated with greater bone loss and increased bone fractures. Osteoporos Int. 2008 Aug;19(8):1161-6.
• Referans13 Bagger YZ, Tankó LB, Alexandersen P, Qin G, Christiansen C. Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip. J Intern Med. 2006;259(6):598–605.
• Referans14 Adragao T, Herberth J, Branscum AJ, Ferreira A, Frazao JM, Curto D, et al. Low Bone Volume — A Risk Factor for Coronary Calcifications in Hemodialysis Patients. Clin J Am Soc Nephrol. 2009 Feb; 4(2): 450–455.
• Referans15 Coen G, Ballanti P, Mantella D, Manni M, Lippi B, Pierantozzi A, et al. Bone turnover, osteopenia and vascular calcifications in hemodialysis patients: A histomorphometric and multislice CT study. Am J Nephrol. 2009;29(3):145–52.
• Referans16 Gölge UH, Pazarci O, Kilinç S, Nusran G, Kaymaz B, Göksel F, et al. The treatment of intertrochanteric fractures comparison of PFN and hemiarthroplasty 3-year mortality study. Acta Orthop Belg. 2016;82(3).
• Referans17 Braithwaite RS1, Col NF, Wong JB.. Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc. 2003;51(3):364–70.
• Referans18 Johnell O, Kanis JA. An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos Int. 2004;15(11):897–902.
• Referans19 Liu Y, Wang Z, Xiao W. Risk factors for mortality in elderly patients with hip fractures: a meta-analysis of 18 studies. Aging Clin Exp Res. 2018 Apr;30(4):323-330.
• Referans20 Moran CG, Wenn RT, Sikand M, Taylor AM. Early mortality after hip fracture: Is delay before surgery important? J Bone Jt Surg - Ser A. 2005;87(3):483–9.